BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21999932)

  • 1. Phosphorylation status of heat shock protein 27 plays a key role in gemcitabine-induced apoptosis of pancreatic cancer cells.
    Nakashima M; Adachi S; Yasuda I; Yamauchi T; Kawaguchi J; Itani M; Yoshioka T; Matsushima-Nishiwaki R; Hirose Y; Kozawa O; Moriwaki H
    Cancer Lett; 2011 Dec; 313(2):218-25. PubMed ID: 21999932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Clinical Significance of Phosphorylated Heat Shock Protein 27 (HSPB1) in Pancreatic Cancer.
    Okuno M; Adachi S; Kozawa O; Shimizu M; Yasuda I
    Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ratio of phosphorylated HSP27 to nonphosphorylated HSP27 biphasically acts as a determinant of cellular fate in gemcitabine-resistant pancreatic cancer cells.
    Kang D; Choi HJ; Kang S; Kim SY; Hwang YS; Je S; Han Z; Kim JH; Song JJ
    Cell Signal; 2015 Apr; 27(4):807-17. PubMed ID: 25615626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active hexose-correlated compound down-regulates HSP27 of pancreatic cancer cells, and helps the cytotoxic effect of gemcitabine.
    Suenaga S; Kuramitsu Y; Kaino S; Maehara S; Maehara Y; Sakaida I; Nakamura K
    Anticancer Res; 2014 Jan; 34(1):141-6. PubMed ID: 24403454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of heat shock protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis.
    Guo Y; Ziesch A; Hocke S; Kampmann E; Ochs S; De Toni EN; Göke B; Gallmeier E
    J Cell Mol Med; 2015 Feb; 19(2):340-50. PubMed ID: 25331547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of p38 mitogen-activated protein kinase in gemcitabine-induced apoptosis in human pancreatic cancer cells.
    Habiro A; Tanno S; Koizumi K; Izawa T; Nakano Y; Osanai M; Mizukami Y; Okumura T; Kohgo Y
    Biochem Biophys Res Commun; 2004 Mar; 316(1):71-7. PubMed ID: 15003513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-gamma down-regulates heat shock protein 27 of pancreatic cancer cells and helps in the cytotoxic effect of gemcitabine.
    Mori-Iwamoto S; Taba K; Kuramitsu Y; Ryozawa S; Tanaka T; Maehara S; Maehara Y; Okita K; Nakamura K; Sakaida I
    Pancreas; 2009 Mar; 38(2):224-6. PubMed ID: 19238023
    [No Abstract]   [Full Text] [Related]  

  • 8. Heat-shock protein 27 is phosphorylated in gemcitabine-resistant pancreatic cancer cells.
    Taba K; Kuramitsu Y; Ryozawa S; Yoshida K; Tanaka T; Maehara S; Maehara Y; Sakaida I; Nakamura K
    Anticancer Res; 2010 Jul; 30(7):2539-43. PubMed ID: 20682980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of phosphorylated heat shock protein 27 on the prognosis of pancreatic cancer.
    Okuno M; Yasuda I; Adachi S; Nakashima M; Kawaguchi J; Doi S; Iwashita T; Hirose Y; Kozawa O; Yoshimi N; Shimizu M; Moriwaki H
    Oncotarget; 2016 Mar; 7(12):14291-9. PubMed ID: 26895107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active Hexose-correlated Compound Down-regulates Heat Shock Factor 1, a Transcription Factor for HSP27, in Gemcitabine-resistant Human Pancreatic Cancer Cells.
    Tokunaga M; Baron B; Kitagawa T; Tokuda K; Kuramitsu Y
    Anticancer Res; 2015 Nov; 35(11):6063-7. PubMed ID: 26504030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of p38 mitogen-activated protein kinase is necessary for gemcitabine-induced cytotoxicity in human pancreatic cancer cells.
    Koizumi K; Tanno S; Nakano Y; Habiro A; Izawa T; Mizukami Y; Okumura T; Kohgo Y
    Anticancer Res; 2005; 25(5):3347-53. PubMed ID: 16101149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN suppresses SPARC-induced pMAPKAPK2 and inhibits SPARC-induced Ser78 HSP27 phosphorylation in glioma.
    Alam R; Schultz CR; Golembieski WA; Poisson LM; Rempel SA
    Neuro Oncol; 2013 Apr; 15(4):451-61. PubMed ID: 23382286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MAPK-activated protein kinase 2 mediates gemcitabine sensitivity in pancreatic cancer cells.
    Köpper F; Binkowski AM; Bierwirth C; Dobbelstein M
    Cell Cycle; 2014; 13(6):884-9. PubMed ID: 24556918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sec6 enhances cell migration and suppresses apoptosis by elevating the phosphorylation of p38 MAPK, MK2, and HSP27.
    Tanaka T; Iino M; Goto K
    Cell Signal; 2018 Sep; 49():1-16. PubMed ID: 29729335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway.
    Adesso L; Calabretta S; Barbagallo F; Capurso G; Pilozzi E; Geremia R; Delle Fave G; Sette C
    Oncogene; 2013 Jun; 32(23):2848-57. PubMed ID: 22797067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of heat shock protein 27 antagonizes TNF-α induced HeLa cell apoptosis via regulating TAK1 ubiquitination and activation of p38 and ERK signaling.
    Qi Z; Shen L; Zhou H; Jiang Y; Lan L; Luo L; Yin Z
    Cell Signal; 2014 Jul; 26(7):1616-25. PubMed ID: 24686082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OGX-427 inhibits tumor progression and enhances gemcitabine chemotherapy in pancreatic cancer.
    Baylot V; Andrieu C; Katsogiannou M; Taieb D; Garcia S; Giusiano S; Acunzo J; Iovanna J; Gleave M; Garrido C; Rocchi P
    Cell Death Dis; 2011 Oct; 2(10):e221. PubMed ID: 22012255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics finding heat shock protein 27 as a biomarker for resistance of pancreatic cancer cells to gemcitabine.
    Mori-Iwamoto S; Kuramitsu Y; Ryozawa S; Mikuria K; Fujimoto M; Maehara S; Maehara Y; Okita K; Nakamura K; Sakaida I
    Int J Oncol; 2007 Dec; 31(6):1345-50. PubMed ID: 17982661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis.
    Shi Y; Ma IT; Patel RH; Shang X; Chen Z; Zhao Y; Cheng J; Fan Y; Rojas Y; Barbieri E; Chen Z; Yu Y; Jin J; Kim ES; Shohet JM; Vasudevan SA; Yang J
    Cell Death Dis; 2015 Aug; 6(8):e1841. PubMed ID: 26247726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitogen-activated protein kinases and chemoresistance in pancreatic cancer cells.
    Zhao Y; Shen S; Guo J; Chen H; Greenblatt DY; Kleeff J; Liao Q; Chen G; Friess H; Leung PS
    J Surg Res; 2006 Dec; 136(2):325-35. PubMed ID: 17054996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.